A groundbreaking milestone has been reached in the fight against malaria. Novartis announced today that its revolutionary therapy has received formal approval to address malaria in newborns and infants, signaling a major advancement in global health. This cutting-edge drug will now be available in countries where malaria is most prevalent, providi